Japan’s PMDA To Roll Out New Safety Infrastructure And Drug Development Support
This article was originally published in PharmAsia News
Executive Summary
After successfully reducing Japan’s drug and device approval lag, PMDA Chief Executive Tatsuya Kondo is ready to support drug development with an emphasis on regulatory science.